Nanoneedle technology licensed for early disease detection, biomarker discovery, and more

https://otd.harvard.edu/news/nanone...for-early-disease-detection-biomarker-discov/

 

It sounds somewhat like "VirScan," a nanotechnology that also came out of Harvard around 2015 that was said to be able to reveal your entire history of viral infections from a single drop of blood. This newer technology seems like it might be even more sensitive.

This would be different from the nanoneedle tech being developed at Stanford University, which, so far as I know, measures electrical impedance.

 

Harvard research

https://engineering.lehigh.edu/news...caroline-ferguson-improving-disease-diagnosis

(video is from 2021)

 

Would love to find her on Twitter.

 

NonoMosaic Unveils a Method to Enable Proteomics by Combining Aptamers and Antibodies on it's MosaicNeedle Platform at 2022 AACR

"Enabling both aptamers and antibodies as the affinity probes and demonstrating high performance with both reagents on the Tessie™ instrument paves the way to accurately measure the expression of one or more proteoforms of every protein-coding gene", said Qimin Quan, Chief Scientific Officer of NanoMosaic, "The ultra-high plexing capability allows proteome-level detection with low sample volume requirement and at high throughput. The simple workflow makes it easy for scientists to develop home-brew assays on high-value targets from the discovery phase." Quan concluded.


https://finance.yahoo.com/news/nanomosaic-unveils-method-enable-proteomics-124700025.html

https://www.prnewswire.com/news-rel...aicneedle-platform-at-2022-aacr-301516671.htm